SG Americas Securities
TPTX

SG Americas Securities’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

SG Americas Securities’s Portfolio TPTX Stock Details TPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-62,660
Closed -$4.71M – 3693
2022
Q2 		$4.71M Buy
62,660
+39,962
+176% +$1.78M 0.05% 316
2022
Q1 		$609K Buy
22,698
+12,722
+128% +$428K ﹤0.01% 1761
2021
Q4 		$476K Sell
9,976
-43,000
-81% -$1.92M ﹤0.01% 2200
2021
Q3 		$3.52M Buy
52,976
+29,939
+130% +$2.13M 0.02% 792
2021
Q2 		$1.8M Sell
23,037
-2,639
-10% -$195K 0.01% 1188
2021
Q1 		$2.43M Buy
25,676
+4,103
+19% +$488K 0.01% 920
2020
Q4 		$2.63M Buy
21,573
+15,098
+233% +$1.65M 0.01% 905
2020
Q3 		$566K Sell
6,475
-961
-13% -$66.9K ﹤0.01% 1550
2020
Q2 		$480K Buy
7,436
+980
+15% +$56.5K ﹤0.01% 2127
2020
Q1 		$288K Buy
6,456
+2,674
+71% +$142K ﹤0.01% 2269
2019
Q4 		$236K Sell
3,782
-35,153
-90% -$1.67M ﹤0.01% 2363
2019
Q3 		$1.46M Buy
+38,935
New +$1.69M 0.01% 1172

SG Americas Securities's TPTX Position: Q3 2022 in Review

SG Americas Securities sold out of Turning Point Therapeutics, Inc. Common Stock (TPTX) in Q3 2022, closing a stake of 62,660 shares — an estimated $4.71M sold.

SG Americas Securities first reported a position in TPTX in Q3 2019 and held it in 12 quarters. The position peaked at $4.71M in Q2 2022. 0 funds tracked by Wall St. Rank hold TPTX as of Q3 2022.

  • SG Americas Securities reported no remaining Turning Point Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • SG Americas Securities sold 62,660 Turning Point Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $4.71M.
  • SG Americas Securities first reported a position in Turning Point Therapeutics, Inc. Common Stock in Q3 2019 and held it in 12 quarters.
  • SG Americas Securities's Turning Point Therapeutics, Inc. Common Stock position peaked at $4.71M in Q2 2022.
  • 0 funds tracked by Wall St. Rank held Turning Point Therapeutics, Inc. Common Stock as of Q3 2022.

Based on SG Americas Securities's 13F filing for Q3 2022, filed 31 Oct 2022.